HF
EWTX icon

HRT Financial’s Edgewise Therapeutics EWTX Stock Holding History

HRT Financial’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52,203
Closed -$846K – 3394
2025
Q3 		$846K Buy
+52,203
New +$740K ﹤0.01% 1616
2025
Q1 		– Sell
-17,113
Closed -$456K – 2745
2024
Q4 		$456K Sell
17,113
-79,296
-82% -$2.52M ﹤0.01% 1502
2024
Q3 		$2.57M Buy
+96,409
New +$1.92M 0.01% 777
2024
Q1 		– Sell
-38,788
Closed -$424K – 2528
2023
Q4 		$424K Buy
+38,788
New +$272K ﹤0.01% 1444

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

HRT Financial's EWTX Position: Q4 2025 in Review

HRT Financial sold out of Edgewise Therapeutics (EWTX) in Q4 2025, closing a stake of 52,203 shares — an estimated $846K sold.

HRT Financial first reported a position in EWTX in Q4 2023 and held it in 4 quarters. The position peaked at $2.57M in Q3 2024. 199 funds tracked by Wall St. Rank hold EWTX as of Q4 2025.

  • HRT Financial reported no remaining Edgewise Therapeutics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 52,203 Edgewise Therapeutics shares in Q4 2025, an estimated $846K.
  • HRT Financial first reported a position in Edgewise Therapeutics in Q4 2023 and held it in 4 quarters.
  • HRT Financial's Edgewise Therapeutics position peaked at $2.57M in Q3 2024.
  • 199 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.